Net profit of Nectar Lifescience rose 399.36% to Rs 7.84 crore in the quarter ended December 2024 as against Rs 1.57 crore during the previous quarter ended December 2023. Sales rose 0.48% to Rs 454.33 crore in the quarter ended December 2024 as against Rs 452.16 crore during the previous quarter ended December 2023.
| Particulars | Quarter Ended | ||
| Dec. 2024 | Dec. 2023 | % Var. | |
| Sales | 454.33 | 452.16 | 0 |
| OPM % | 9.84 | 9.33 | - |
| PBDT | 28.16 | 17.83 | 58 |
| PBT | 12.55 | 2.46 | 410 |
| NP | 7.84 | 1.57 | 399 |
Powered by Capital Market - Live News